Atherosclerosis and Arteriolosclerosis: Clinical and Pathological Study Guide

General Overview of Arteriolosclerosis

Arteriolosclerosis serves as a clinical term referring to any thickening and hardening of the arterioles. It represents a spectrum of vascular changes that primarily affect small-caliber arteries and arterioles. While often used interchangeably with larger-scale hardening of the arteries, arteriolosclerosis is specifically focused on the microvasculature and is frequently associated with aging, chronic hypertension, and systemic metabolic conditions such as diabetes mellitus.

Classification of Arteriosclerosis: Senile and Monckeberg Sclerosis

Senile arteriosclerosis is a variant of vessel hardening occurring as a consequence of the natural aging process. In this condition, aging leads to a gradual, diffuse distension and increasing tortuosity of the large arteries. Within the medium-sized muscular arteries, there is a disproportionate increase in the thickness of the intima due to fibrosis. The internal elastic lamina also undergoes thickening by a process of reduplication and may eventually develop gaps. Concurrently, the medial muscle layers decrease in volume as the collagen content increases, leading to a loss of elasticity.

Monckeberg's Sclerosis, also known as medial calcific sclerosis or Monckeberg's arteriosclerosis, is characterized by a medial rather than an intimal lesion. Unlike atherosclerosis, this condition does not narrow the vessel lumen; consequently, ischemia does not typically result from this condition. It involves circumferential medial calcification specifically in medium-sized muscular arteries, appearing most frequently in the extremities. It is often accompanied by metaplastic bone and bone marrow formation within the vessel wall. One proposed etiology for this type of sclerosis is prolonged arterial spasm.

Hypertensive Arteriolosclerosis: Categories and Pathological Features

Hypertensive arteriolosclerosis is the thickening and narrowing of small arteries and arterioles fundamentally caused by chronic hypertension (HPT). The pathology results from two primary mechanisms: plasma protein leakage, known as hyaline change, or muscle proliferation, known as hyperplastic change. These processes damage vessel walls and restrict blood flow to essential organs, most commonly affecting the kidneys, the brain, and the retina.

Hyaline arteriolosclerosis is characterized by the accumulation of an amorphous, eosinophilic, or "glassy" material within the vessel walls. These materials are primarily plasma proteins deposited via a process of plasma insudation. This accumulation leads to the thickening of the arteriolar wall and subsequent narrowing of the lumen. This form is common in benign, chronic hypertension as well as in diabetes mellitus. A classic example is the hyaline vascular change involving the afferent arteriole in the kidney, which is often associated with glomerulosclerosis.

Hyperplastic arterioloscleroisis occurs specifically in cases of severe or malignant hypertension. It presents with a distinct "onion-skin" appearance, which is a concentric, laminated thickening of the vessel walls. This structure is formed by the proliferation of smooth muscle cells and the basement membrane, leading to significant luminal narrowing and potential acute vascular injury.

Atherosclerosis: Epidemiology and Clinical Significance

Atherosclerosis underlies the basic pathogenesis of coronary, cerebral, and peripheral vascular diseases. It is responsible for more morbidity and mortality in the Western world than any other clinical disorder, accounting for approximately half of all deaths ($50\%$). It is a disease specifically of the arterial intima, affecting elastic arteries and large-to-medium-sized muscular arteries in a patchy, irregular fashion. Notably, atherosclerosis does not involve small vessels or arterioles.

The disease is characterized by the formation of plaque-like intimal elevations (atheromatous plaques), which result from the accumulation of lipids (primarily cholesterol), complex carbohydrates, calcium, and blood, all of which are surrounded by fibrous tissue. These plaques reduce the diameter of the lumen and weaken the underlying media. In recent years, the incidence of the disease has been increasing among Black Africans. Dietary and physical habits associated with prosperity and modern civilization are believed to play a significant role in its development.

Risk Factors for the Development of Atherosclerosis

The etiology of atherosclerosis is multifactorial, and a wide variety of risk factors correlate positively with its incidence and severity. These can be divided into nonmodifiable constitutional factors and modifiable factors. The traditional nonmodifiable major risk factors include increasing age, male gender, genetic abnormalities, and a family history of cardiovascular disease. The major modifiable risk factors include hyperlipidemia, systemic hypertension, cigarette smoking, diabetes mellitus (often monitored via $HbA1c\%$), and chronic inflammation.

Novel risk factors that have gained clinical attention include a family history of myocardial infarction occurring prior to the age of $60$ and elevated levels of serum C-reactive protein. Minor or inconclusive risk factors include a sedentary lifestyle, low socioeconomic status, low birth weight, Type A personality, obesity, infection with Chlamydia pneumoniae, and specific dietary factors. Hyperlipidemia, specifically hypercholesterolemia (whether familial or diet-induced), is the major risk factor for patients under the age of $45$. The risk of heart disease is directly proportional to serum cholesterol levels.

Cholesterol is transported in association with lipoproteins. Cholesterol associated with low-density lipoprotein (LDL) tends to be deposited in the arteries and peripheral tissues. Conversely, high-density lipoprotein (HDL) is associated with the mobilization of cholesterol from existing deposits and is considered protective. HDL levels are typically lower in males, smokers, diabetics, and individuals who do not exercise. Furthermore, hypertension accelerates the development of atherosclerosis five-fold in systemic arteries and can also lead to it in the pulmonary artery in the context of pulmonary hypertension. Hypertension is the dominant major risk factor in patients over the age of $45$. While atherosclerosis increases with age due to longer exposure to aetiological factors, it is rare in individuals under the age of $30$.

Pathogenesis and the Response to Injury Model

The pathogenesis of atherosclerosis is currently understood via the "Response to Injury" model. Lesion progression occurs through the interaction of modified lipoproteins, macrophages, and T lymphocytes with endothelial cells (ECs) and smooth muscle cells (SMCs) of the arterial wall. The sequence of cellular interactions is as follows:

1. Chronic endothelial injury and dysfunction: Caused by factors such as hyperlipidemia, hypertension, smoking, homocysteine, hemodynamic factors, toxins, viruses, and immune reactions. This leads to increased vascular permeability, leukocyte adhesion, and potential thrombosis.
2. Accumulation of lipoproteins: Primarily LDL and its oxidized forms accumulate within the vessel wall (intima).
3. Monocyte adhesion and emigration: Monocytes adhere to the endothelium, migrate into the intima, and transform into macrophages and foam cells.
4. Platelet adhesion occurs at the site of injury.
5. Factor release: Activated platelets, macrophages, and vascular wall cells release factors that induce SMC recruitment from the media or from circulating precursors.
6. SMC proliferation and ECM production: Smooth muscle cells proliferate and produce extracellular matrix (ECM) components such as collagen and proteoglycans. T cells are also recruited.
7. Lipid accumulation: Lipids accumulate both extracellularly and within cells (macrophages and SMCs). Foam cells are formed when these cells engulf modified lipids via scavenger and LDL-receptor–related proteins.
8. Calcification: Calcification of the ECM and necrotic debris occurs in the late stages of pathogenesis.

Inflammatory mediators like Interleukin-1 ($IL-1$) and monocyte chemoattractant protein-1 ($MCP-1$) are central to the recruitment of these cells and the orchestration of the inflammatory response.

Morphology of Fatty Streaks and Atherosclerotic Plaques

Fatty streaks are the earliest lesions of atherosclerosis. They are composed primarily of lipid-filled foamy macrophages. Grossly, they begin as small, flat, yellow macules that can coalesce into elongated streaks of $1\,cm$ or longer. They are not significantly raised and do not cause flow disturbance. Interestingly, fatty streaks are found in the aortas of virtually all infants and adolescents, regardless of risk factors. Evidence suggests a temporal evolution, as coronary fatty streaks form in adolescence at the same anatomic sites where plaques later develop.

Atherosclerotic plaques (atheromas) are the hallmark of the disease. They are yellow-tan, raised elevations that vary in size but can coalesce. These lesions are patchy and rarely involve the entire circumference of the vessel. In descending order of frequency, the most extensively involved vessels are:

1. The lower abdominal aorta and iliac arteries.
2. The coronary arteries.
3. The popliteal arteries.
4. The internal carotid arteries.
5. The vessels of the Circle of Willis.

Atherosclerotic plaques consist of four principal components: cells (SMCs, macrophages, and T lymphocytes), ECM (collagen, elastic fibers, and proteoglycans), intracellular and extracellular lipids, and calcifications in older lesions. These plaques are dynamic, changing and enlarging due to cell death, remodeling of the ECM, and organization of superimposed thrombi.

Clinical Consequences and Plaque Complications

Atherosclerotic plaques are susceptible to several clinically significant pathologic changes:

1. Rupture, ulceration, or erosion: This exposes the blood to highly thrombogenic substances, leading to thrombosis that can partially or completely occlude the lumen. This is often the trigger for fatal myocardial infarction.
2. Hemorrhage into a plaque: Rupture of the fibrous cap or the thin-walled vessels of neovascularization (small new blood vessels) within the plaque can cause an internal hematoma. This may expand the plaque or trigger its rupture.
3. Atheroembolism: Plaque rupture can discharge debris (such as cholesterol clefts) into the bloodstream, creating microemboli.
4. Aneurysm formation: Pressure-induced or ischemic atrophy of the underlying media leads to a loss of elastic tissue, causing wall weakness and potential rupture.

Microscopic and Gross Observations

Gross examination of the aorta reveals categories of disease ranging from mild atherosclerosis (fibrous plaques) to severe disease characterized by diffuse, complicated lesions, ulcerated plaques, and lesions with overlying thrombus. Histologically, a plaque (such as one in a coronary artery) demonstrates a fibrous cap ($F$) and a central necrotic core ($C$) containing cholesterol and other lipids.

Advanced plaques may be "eccentric," meaning they do not involve the whole circumference of the wall. Techniques such as Masson trichrome stain can be used to visualize collagen (staining blue), while elastin stains (black) reveal thin or attenuated internal and external elastic membranes. High-power views often reveal "cholesterol clefts" within the lipid-rich core, which represent spaces where cholesterol crystals once resided before being dissolved during tissue processing. Inflammatory cells, calcification, and neovascularization are typically found at the junction of the fibrous cap and the necrotic core.